Five things for pharma marketers to know: Thursday, January 25, 2018

Senate confirms Azar as HHS head; Spark licenses Luxturna to Novartis outside the U.S.; Glaxo and J&J top index of superbug combatants

from Most popular articles from Medical Marketing and Media http://ift.tt/2nbZP6e